unknown
Stage
About
Genocea Biosciences is a clinical-stage biotechnology company focused on developing personalized cancer immunotherapies through its proprietary ATLAS platform to identify immune targets for individual patients.
Explore Genocea Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.